Testing the WeCare Intervention to Address Mental Health and Medication Adherence Challenges Among MSM in South Africa
3 other identifiers
interventional
60
1 country
1
Brief Summary
The goal of this clinical trial is to learn if the WeCare intervention-an adapted Friendship Bench program that integrates problem-solving therapy, minority-stress-informed content, and explicit PrEP/ART adherence skills-improves mental health and HIV medication adherence among men who have sex with men (MSM). It will also assess the safety, acceptability, and feasibility of delivering WeCare through trained lay coaches in community clinics. Main questions the trial aims to answer:
- Does WeCare reduce symptoms of depression and anxiety among MSM?
- Does WeCare improve PrEP and ART adherence and increase rates of viral suppression among participants on ART?
- Is WeCare acceptable, feasible, and safe when delivered by lay coaches in POP INN clinics compared with usual care?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv-infections
Started Dec 2025
Shorter than P25 for not_applicable hiv-infections
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 7, 2025
CompletedFirst Posted
Study publicly available on registry
November 10, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
November 10, 2025
November 1, 2025
1.3 years
November 7, 2025
November 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Assessment : Modified version of the Session Evaluation Form (SEF) score
13-item SEF measuring perceived feasibility, acceptability, and intervention utility. Composite scores are calculated with higher scores indicating more perceived feasibility and acceptability.
Baseline, Month 3, Month 6
Change in Client Satisfaction Survey (CSQ-8) score
8-item CSQ assessing satisfaction with recruitment, retention, and intervention procedures, engagement data from the trial (e.g., completion of sessions). Composite scores are calculated with higher scores indicating more satisfaction.
Baseline, Month 3, Month 6
Mental health measures: Change in The Patient Health Questionnaire (PHQ-9) scores
The Patient Health Questionnaire (PHQ-9) measures the frequency of depression symptoms within the past two weeks. The PHQ-9 comprises five categories, where a cut-off point of 0-4 indicates no depressive symptoms, 5-9 mild depressive symptoms, 10-14 moderate depressive symptoms, 15-19 moderately-severe depressive symptoms, and 20-27 severe depressive symptoms
Baseline, Month 3, Month 6
Change in Psychological stress: WHO Self-Reporting Questionnaire-20 (SRQ-20) score
The WHO Self-Reporting Questionnaire-20 (SRQ-20) includes items to reflect symptoms of depression, anxiety and psychosomatic complaints, which are all together grouped under the heading of common mental disorder (CMD) and have been found to detect probable mental health disorder with satisfactory accuracy
Baseline, Month 3, Month 6
Change in ART adherence
ART adherence will be defined as a suppressed HIV viral load (HIV-1 RNA viral load \<200 copies/mL) in a blood sample
Baseline, Month 3, Month 6
Change in PrEP adherence
PrEP adherence will be defined as an intracellular Tenofovir Diphosphate (TFV-DP) concentration ≥700 fmol/punch in a dried blood spot (DBS) sample. This concentration was found consistent with an average of ≥4 doses/week in the prior month in a directly observed study among men and women in the United States
Baseline, Month 3, Month 6
Secondary Outcomes (2)
Self reported medication adherence
Baseline, Month 3, Month 6
Status neutral composite adherence
Baseline, Month 3, Month 6
Study Arms (2)
Friendship Bench (FB) arm
EXPERIMENTALControl Arm
OTHERInterventions
The intervention is an adapted Friendship Bench (FB) for MSM in South Africa that integrates counseling on HIV medication adherence and the mental health-adherence relationship. The intervention includes up to 4 individual sessions and up to 4 group sessions; individual sessions may be delivered in person or online (Inuka-style), while all group sessions are in person.
The control group will receive enhanced standard care at POP INN Wellness Clinic: psychoeducation for all PrEP/ART enrollees, free medication, access to ongoing support groups, and referrals provided by the clinic.
Eligibility Criteria
You may qualify if:
- Male
- reports sexual intercourse with a man in the past 6 months
- reside in the Johannesburg metropolitan area with no plans to relocate during the next 6 months
- ability to communicate in English
- current prescription for any ART regimen (HIV-positive participants) or daily oral PrEP (HIV-negative participants) at the POP INN clinic.
- HIV positive participant only: unsuppressed HIV viral load (HIV-1 RNA viral load ≥200 copies/mL) in the sample collected in the past six months
- HIV negative participants only: Self-reported challenges adhering to daily oral PrEP (i.e miss 3 or more tablets per week)
- Moderate symptoms of depression during past 2 weeks (score on the PHQ-9 ≥10 and \<20)
- Ability to understand and provide informed consent.
You may not qualify if:
- Presently engaged in mental health therapy.
- Participated in qualitative phase of WeCare study (AUR2-18-419) or open-pilot (present study).
- Refuses audio recording of the in-person or online individual counselling session
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
Aurum Institute
Johannesburg, South Africa
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Don Operario, PhD
Rollins School of Public Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 7, 2025
First Posted
November 10, 2025
Study Start
December 1, 2025
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
November 10, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Data will be shared following publication
Data will be shared with researchers who submit a methodologically sound proposal. Data will be collected by Aurum; Aurum will share de-identified data with Emory (including data dictionaries).